DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 4, 2001, Pages 1168-1173

  Sereno, D ^a   Roy, G ^a   Loup Lemesre, J ^a   Papadopoulou, B ^a   Ouellette, M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIMONY TARTRATE; LUCIFERASE; MEGLUMINE; PENTAMIDINE;

AMASTIGOTE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA DETERMINATION; DRUG SCREENING; ELECTROPORATION; ENZYME ACTIVITY; GENETIC TRANSFORMATION; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; STAINING;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; DNA, RECOMBINANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ELECTROPORATION; GENES, REPORTER; GERM-FREE LIFE; HUMANS; LEISHMANIA INFANTUM; LUCIFERASES; PARASITIC SENSITIVITY TESTS; TRANSFECTION; TRANSFORMATION, GENETIC;

EID: 0035077738     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.4.1168-1173.2001     Document Type: Article

References (35)

1. Leishmania and human immunodeficiency virus coinfection: The first 10 years
2. Semiautomated assessment of in vitro activity of potential antileishmanial drugs
3. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages
4. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis
5. Drug cytotoxicity assay for African trypanosomes and Leishmania species
6. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galactosidase
7. An axenic amastigote system for drug screening
8. DNA-mediated transformation of bloodstream-form Trypanosoma brucei
9. Genetic manipulation of kinetoplastida
10. Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis
11. Leishmania mexicana: Drug sensitivities of promastigotes and transforming amastigotes
12. Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in leishmania by overexpression/selection
13. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes
14. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes
15. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis
16. The promoter for the ribosomal RNA genes of Leishmania chagasi
17. An in vitro model for screening antileishmanial drugs: The human leukaemia monocyte cell line, THP-1
18. Drug resistance in leishmaniasis: Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease
19. Leishmaniasis
20. Leishmania resistant to sodium stibogluconate: Drug-associated macrophage-dependent killing
21. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony therapy
22. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages
23. Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae
24. Stable expression of the bacterial neor gene in Leishmania enriettii
25. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
26. Use of Toxoplasma gondii expressing β-galactosidase for colorimetric assessment of drug activity in vitro
27. Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in leishmania amastigotes
28. ABC transporters in Leishmania and their role in drug resistance
29. Antileishmanial activity of sodium stibogluconate fractions
30. Episomal and stable expression of the luciferase reporter gene for quantifying Leishmattia spp. infections in macrophages and in animal models
31. Shuttle cosmid vectors for the trypanosomatid parasite Leishmania
32. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action
33. Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum
34. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents
35. Cloning of leishmania nucleoside transporter genes by rescue of a transport-deficient mutant